BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3968680)

  • 1. Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids and selected lipophilic alcohols.
    Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
    J Med Chem; 1985 Feb; 28(2):171-7. PubMed ID: 3968680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
    Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
    J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.
    Ryu EK; Ross RJ; Matsushita T; MacCoss M; Hong CI; West CR
    J Med Chem; 1982 Nov; 25(11):1322-9. PubMed ID: 7143370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside conjugates as potential antitumor agents. 3. Synthesis and antitumor activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of corticosteroids.
    Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
    J Med Chem; 1980 Dec; 23(12):1343-7. PubMed ID: 7452687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
    J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity.
    Hong CI; West CR; Bernacki RJ; Tebbi CK; Berdel WE
    Lipids; 1991 Dec; 26(12):1437-44. PubMed ID: 1819747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
    Rosowsky A; Kim SH; Ross J; Wick MM
    J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside conjugates. 14. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids with improved water solubility.
    Hong CI; Nechaev A; Kirisits AJ; Vig R; Hui SW; West CR
    J Med Chem; 1995 May; 38(10):1629-34. PubMed ID: 7752187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
    J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids as potential antitumor agents.
    Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1105-12. PubMed ID: 6684555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of prednisolone and prednisone.
    Hong CI; Nechaev A; West CR
    J Med Chem; 1979 Nov; 22(11):1428-32. PubMed ID: 118258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
    Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.
    Kodama K; Morozumi M; Saitoh K; Kuninaka A; Yoshino H; Saneyoshi M
    Jpn J Cancer Res; 1989 Jul; 80(7):679-85. PubMed ID: 2507491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
    Kucera GL; Capizzi RL
    Cancer Res; 1992 Jul; 52(14):3886-91. PubMed ID: 1377599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of 1-beta-D-arabinofuranosylcytosine conjugates of lipids on the growth and metastasis of Lewis lung carcinoma.
    Berdel WE; Danhauser S; Hong CI; Schick HD; Reichert A; Busch R; Rastetter J; Vogler WR
    Cancer Res; 1988 Feb; 48(4):826-9. PubMed ID: 3338080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside conjugates. 13. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of thioether lipids with improved water solubility.
    Hong CI; Nechaev A; Kirisits AJ; Vig R; West CR
    J Med Chem; 1993 Jun; 36(12):1785-90. PubMed ID: 8510106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.